最新消息 - 臺灣血液與腫瘤藥學會

2026-01-05

Hematology/Oncology Update from NEJM

Hematology/Oncology Update January 2026
Original Research

Original Article \| Dec 18, 2025 \| CME \| ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer T. Powles and Others Editorial ctDNA-Guided Therapy in Bladder Cancer — Ready?	Quick Take ctDNA-Guided Atezolizumab in Bladder Cancer
Original Article \| Dec 18, 2025 \| Noninferiority of One HPV Vaccine Dose to Two Doses A.R. Kreimer and Others Editorial Evidence to Action — Single-Dose HPV Vaccination and Cervical HPV Infection	Quick Take One vs. Two Doses of HPV Vaccine
Original Article \| Dec 09, 2025 Ianalumab plus Eltrombopag in Immune Thrombocytopenia A. Cuker and Others
Original Article \| Dec 07, 2025 Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B S.W. Pipe and Others Original Article Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
Original Article \| Dec 11, 2025 \| Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer X. Sheng and Others Editorial Disitamab Vedotin plus Toripalimab — New Players in Urothelial Carcinoma	Quick Take Disitamab Vedotin–Toripalimab in Urothelial Cancer
Original Article \| Dec 06, 2025 Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia O. Al-Sawaf and Others
Original Article \| Dec 10, 2025 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer S. Loibl and Others
Original Article \| Dec 09, 2025 Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma L.J. Costa and Others
Original Article \| Dec 07, 2025 Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab S. Kumar and Others
Original Article \| Dec 08, 2025 Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia R. Chiesa and Others
Original Article \| Dec 07, 2025 Brief Report: Prime Editing for p47phox-Deficient Chronic Granulomatous Disease J.L. Gori and Others
Correspondence \| Dec 11, 2025 Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse Events

Multimedia

Multimedia 1

Images in Clinical Medicine
Merkel-Cell Carcinoma

Perspective and Commentary

Perspective \| Dec 27, 2025 Where Do I Put This? D. Chammas
Editorial \| Dec 18, 2025 Evidence to Action — Single-Dose HPV Vaccination and Cervical HPV Infection R.V. Barnabas
Perspective \| Dec 18, 2025 \| FREE Reducing Tobacco Use Worldwide: The Epidemic of Tobacco Harms among People with Mental Health Conditions S. Gilbody, G. Bhatt, and K.P. Muliyala
Editorial \| Dec 18, 2025 ctDNA-Guided Therapy in Bladder Cancer — Ready? L. Dyrskjøt
Clinical Implications of Basic Research \| Dec 11, 2025 Understanding How Aspirin Prevents Metastasis R.E. Langley and J. Burn
Editorial \| Dec 11, 2025 Disitamab Vedotin plus Toripalimab — New Players in Urothelial Carcinoma J. Bedke

購物車